OPKOPKO HEALTH, INC.

Nasdaq opko.com


$ 1.56 $ 0.00 (0 %)    

Monday, 09-Sep-2024 15:59:56 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 1.56
$ 1.56 x 4,451
-- x --
-- - --
$ 0.85 - $ 1.76
3,319,237
na
1.09B
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-01-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-18-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-maintains-outperform-on-opko-health-raises-price-target-to-225

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and raises the price target...

 opko-health-q2-2024-gaap-eps-001-beats-009-estimate-sales-182200m-miss-185190m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.09) by...

 opko-health-stock-is-climbing-whats-going-on

Opko Health shares are trading higher Thursday after the company announced a $100 million share repurchase program. Here's ...

 piper-sandler-maintains-overweight-on-opko-health-lowers-price-target-to-3

Piper Sandler analyst Edward Tenthoff maintains OPKO Health (NASDAQ:OPK) with a Overweight and lowers the price target from ...

 why-opko-health-shares-are-up-after-hours

Opko Health shares are trading higher after-hours Wednesday. The company announced it has entered into a $250 million non-dilut...

Core News & Articles

New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additional E-Commerce Platform...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 opko-health-q1-2024-gaap-eps-012-misses-010-estimate-sales-173700m-miss-182990m-estimate

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) ...

 hc-wainwright--co-reiterates-buy-on-opko-health-maintains-3-price-target

HC Wainwright & Co. reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.

 barrington-research-maintains-outperform-on-opko-health-maintains-15-price-target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and maintains $1.5 price ta...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION